SCHEMBL3341967

SCHEMBL3341967

Nc1nc(Cl)c2c(n1)-c1ccccc1CCC2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 3/20 0.59
HRH4 Q9H3N8 7/20 0.57
ADORA2A P29274 1/20 0.50
ADORA1 P30542 1/20 0.50
KDM4E B2RXH2 2/20 0.49
ALDH1A1 P00352 1/20 0.49
POLB P06746 1/20 0.49
HRH2 P25021 1/20 0.48
HRH1 P35367 1/20 0.48
HRH3 Q9Y5N1 1/20 0.48
ACHE P22303 2/20 0.48
KDR P35968 2/20 0.45
EGFR P00533 1/20 0.44
DRD4 P21917 1/20 0.44
NPC1 O15118 1/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.43
RECQL P46063 1/20 0.43
RAB9A P51151 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4877642 0.91 BCHE (0.57) BCHEHRH4ADORA2AADORA1KDM4E
SCHEMBL14197519 0.84 HRH4 (0.60) BCHEHRH4ADORA2AADORA1KDM4E
SCHEMBL4875418 0.84 BCHE (0.55) BCHEHRH4KDM4EALDH1A1POLB
SCHEMBL2167222 0.82 HRH4 (0.57) BCHEHRH4ADORA2AADORA1KDM4E
SCHEMBL4878240 0.79 HRH4 (0.52) BCHEHRH4ADORA2AADORA1KDM4E
SCHEMBL4875017 0.79 HRH4 (0.39) BCHEHRH4ADORA2AADORA1HRH2
SCHEMBL4876581 0.79 HRH4 (0.54) BCHEHRH4ADORA2AADORA1KDM4E
SCHEMBL9837155 0.75 DYRK1A (0.54) BCHEHRH4KDM4EALDH1A1POLB
SCHEMBL6491511 0.75 BCHE (1.00) BCHEKDM4EALDH1A1ACHEMAPK1
SCHEMBL10329707 0.74 BCHE (0.53) BCHEHRH4ADORA2AADORA1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735411-B2 Macrocyclic benzofused pyrimidine derivatives ABBVIE INC. (US) 2014-05-27 US disclosed
US-8268846-B2 Amino heterocyclic linked pyrimidine derivatives ABBOTT LABORATORIES (US) 2012-09-18 US disclosed
US-20100016344-A1 AMINO HETEROCYCLIC LINKED PYRIMIDINE DERIVATIVES ABBOTT LABORATORIES (US) 2010-01-21 US disclosed
US-20080188452-A1 Macrocyclic Benzofused Pyrimidine Derivatives ABBVIE INC. 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016344-A1 AMINO HETEROCYCLIC LINKED PYRIMIDINE DERIVATIVES DPYD, TYMS, UMPS BCHE 1295/4885HRH4 2024/4885ADORA2A 738/4885
US-20080188452-A1 Macrocyclic Benzofused Pyrimidine Derivatives DPYD, TYMS, UMPS BCHE 1235/4885HRH4 3013/4885ADORA2A 1517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.